Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07116161Not ApplicableRecruiting

Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore

Role: collaborator

NCT05957068Not ApplicableRecruiting

Breast Cancer Exercise Intervention Study

Role: collaborator

NCT05306808Not ApplicableCompleted

Multidisciplinary Rehabilitation Programme for Breast Cancer

Role: collaborator

NCT02524548Not ApplicableCompleted

SMS Reminders to Improve Medication Adherence of Aromatase Inhibitors

Role: collaborator

NCT04159363Not ApplicableUnknown

A Psychosocial Intervention for Patients With Colorectal Cancer and Their Family Caregivers

Role: lead

NCT00465842Terminated

Protein Biomarker in Hepatocellular Carcinoma

Role: collaborator

All 6 trials loaded